|4Nov 25, 9:29 PM ET

Cvijic Christine Mikail 4

4 · Neurogene Inc. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-22
Cvijic Christine Mikail
President and CFO
Transactions
  • Purchase

    Common Stock

    2024-11-22$20.48/sh+24,000$491,40076,844 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.33 to $20.92, inclusive. The reporting person undertakes to provide to Neurogene Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]Includes 24,000 shares held jointly by the reporting person and her spouse, David Cvijic.

Documents

1 file
  • 4
    wk-form4_1732588163.xmlPrimary

    FORM 4